DVx Inc.
3079.TJPXHealthcareMedical - Devices
Latest quote
¥933
+¥1.00 · +0.11%
3079.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteDVx Inc., a Japanese company founded in 1986 and headquartered in Tokyo, specializes in the import and export of medical devices and their accompanying peripheral equipment within Japan. The firm offers a diverse portfolio of products, including those addressing arrhythmia, such as cardiac pacemakers, implantable cardioverter defibrillators, and various electrode and ablation catheters. It also provides ischemia-related solutions, notably excimer laser systems. A significant portion of its offerings includes specialized equipment designed to minimize scatter radiation exposure for medical personnel during fluoroscopy procedures, featuring products like RADPAD (for general protection), RADNEK (for thyroid protection), and RADCAP (for head protection). Additionally, DVx supplies resolution/resolution SD devices and wonder belt products. Beyond sales and distribution, the company is actively involved in the full spectrum of medical device operations, encompassing research, development, manufacturing, repair, and leasing. DVx Inc. further provides general consulting and services related to medical and medical device industries, alongside engaging in medical publishing and market research activities.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Takeshi Hatano
- Listed since
- Apr 25, 2007
- Employees
- 334
Market position
52-week range
Current ¥933
- Open
- ¥933
- Previous close
- ¥932
- Volume
- 5.6K
- 1.69× average
- Average volume
- 3.31K
- Average daily volume
- Market cap
- 9.8B JPY
- Beta
- 0.3
- Market reference 1
- 50-day average
- ¥959.98
- -2.81% below average
- 200-day average
- ¥1,097.39
- -14.98% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 7.55B JPY
- P/E (TTM)
- 41.14×
- P/B (TTM)
- 1.17×
- P/S (TTM)
- 0.17×
- EV / EBITDA
- 7.02×
- Earnings yield
- 1.90%
- Free cash flow yield
- -14.47%
- Dividend yield
- 5.36%
Profitability & efficiency
- Gross margin
- 9.57%
- Operating margin
- 0.52%
- Net margin
- 0.42%
- Return on equity
- 2.55%
- Return on assets
- 0.90%
- Return on invested capital
- 2.30%
Financial health
- Debt / equity
- 0×
- Current ratio
- 1.42×
- Altman Z-score
- 3.39
- Piotroski F-score
- 4 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 55.99B JPY | 50.32B JPY | 45.85B JPY | 47.48B JPY | 45.5B JPY |
| Cost of goods sold | 50.62B JPY | 45.5B JPY | 41.23B JPY | 42.15B JPY | 40.32B JPY |
| Gross profit | 5.37B JPY | 4.82B JPY | 4.62B JPY | 5.33B JPY | 5.18B JPY |
| Research and development | — | 12.22M JPY | 30.99M JPY | 15.43M JPY | 7.93M JPY |
| Selling, general, and administrative | 5.07B JPY | 4.27B JPY | 3.93B JPY | 3.97B JPY | 3.92B JPY |
| Operating expenses | 5.07B JPY | 4.28B JPY | 3.96B JPY | 3.99B JPY | 3.92B JPY |
| Interest income | 4.73M JPY | 3.03M JPY | 1.06M JPY | 1.25M JPY | 80K JPY |
| Interest expense | 881K JPY | 251K JPY | 251K JPY | 125K JPY | — |
| Depreciation and amortization | 770.82M JPY | 577.78M JPY | 432.22M JPY | 391.27M JPY | 366.04M JPY |
| Operating income | 294.06M JPY | 537.46M JPY | 653.15M JPY | 1.34B JPY | 1.25B JPY |
| Net income | 225.38M JPY | 410.12M JPY | 172.91M JPY | 936.18M JPY | 863.02M JPY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 1.67
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
3079.T peers
Continue in GoAI
Research 3079.Tresearch.disclaimer